NCT06301997Active, not recruitingPhase 2
A Herbal Compound for Psoriasis
Evaluation of Therapeutic Effects of ZAX.1400.P03 a Herbal Compound on Clinical Signs of Skin in Psoriasis Patients
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
The goal of this interventional clinical trial study is to compare ZAX.1400.P03 and placebo in Psoriasis patients. The main question it aims to answer is: • Can treatment with ZAX.1400.P03 for 3 weeks improve clinical signs of skin in psoriasis patients? Participants will be divided into two groups of 52 people. One group will use ZAX.1400.P03 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by psoriasis after treatment with ZAX.1400.P03 for 3 weeks.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 104 (actual)
- First submitted
- 4 Mar 2024
- Start date
- 1 Feb 2023
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Fasa University of Medical Sciences
- Diseases
- Psoriasis
- NCT number
- NCT06301997
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 104
- From 1 Feb 2023 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Incidence of drug product allergy
- Occurrence of symptoms of skin, digestive, liver or kidney diseases
Other
- Non-consent of the doctor directly responsible for the patient
- Patient\'s lack of consent to continue for any reason
Who the study is looking for
- Diagnosis of the disease by a doctor
- Age range between 18 and 60 years
- Both sexes (male and female)
- Having written informed consent to participate in the study
- Lack of allergy to food and health products
- Only local tissue involvement and no need to take oral medications
- Absence of underlying diseases and immune deficiency
- Absence of pregnancy and breastfeeding
- Absence of blisters and infection caused by the disease
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fasa university of medical sciences Coordinator of this site? Confirm its status | Fasa | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.